Back
ESC Premium Access

Long vs. short dual antiplatelet therapy in ACS patients treated with prasugrel or ticagrelor and coronary revascularization: a propensity score analysis from the RENAMI registry

Session: ACS diagnosis and treatment
Topic: Pharmacotherapy
Speaker: Doctor F. Fioravanti (Milan, IT)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Francesco Fioravanti

San Raffaele Hospital, Milan (Italy)
0 follower

6 more presentations in this session

Exploring the value of the PRECISE-DAPT score after complex percutaneous coronary intervention to inform dual antiplatelet therapy duration decision-making.

Speaker: Doctor F. Costa (Messina, IT)

Access
Abstract
Slides
Like
Thumbnail

The effect of PCI complexity on the efficacy and safety of dabigatran dual therapy vs warfarin triple therapy in atrial fibrillation: a subgroup analysis from the RE-DUAL PCI trial

Speaker: Doctor C. Cannon (Boston, US)

Access
Abstract
Slides
Like
Thumbnail

Diagnostic evaluation of a new high-sensitive point-of-care troponin I assay

Speaker: Doctor N. Soerensen (Hamburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Diagnostic accuracy of high sensitive cardiac troponin T in patients with suspected acute coronary syndrome and severe chronic kidney disease

Speaker: Doctor B. Alushi (Munich, DE)

Access
Abstract
Slides
Like
Thumbnail

Does complying guidelines matter?

Speaker: Doctor I. Campos (Braga, PT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

ACS diagnosis and treatment

Speakers: Doctor F. Fioravanti, Doctor F. Costa, Doctor C. Cannon, Doctor N. Soerensen, Doctor B. Alushi...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources